Literature DB >> 34078451

Potential applications of aptamers in veterinary science.

Solène Niederlender1, Jean-Jacques Fontaine2, Grégory Karadjian3.   

Abstract

Aptamers are small nucleic acids that fold in a three-dimensional conformation allowing them to bind specifically to a target. This target can be an organic molecule, free or carried in cells or tissues, or inorganic components, such as metal ions. Analogous to monoclonal antibodies, aptamers however have certain advantages over the latter: e.g., high specificity for their target, no to low immunogenicity and easy in vitro selection. Since their discovery more than 30 years ago, aptamers have led to various applications, although mainly restricted to basic research. This work reviews the applications of aptamers in veterinary science to date. First, we present aptamers, how they are selected and their properties, then we give examples of applications in food and environmental safety, as well as in diagnosis and medical treatment in the field of veterinary medicine. Because examples of applications in veterinary medicine are scarce, we explore the potential avenues for future applications based on discoveries made in human medicine. Aptamers may offer new possibilities for veterinarians to diagnose certain diseases-particularly infectious diseases-more rapidly or "at the patient's bedside". All the examples highlight the growing interest in aptamers and the premises of a potential market. Aptamers may benefit animals as well as their owners, breeders and even public health in a "One Health" approach.

Entities:  

Keywords:  Application; Aptamer; Diagnostics; Food and environmental safety; Therapeutics; Veterinary sciences

Year:  2021        PMID: 34078451     DOI: 10.1186/s13567-021-00948-4

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  89 in total

1.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

Review 2.  Analytical applications of aptamers.

Authors:  S Tombelli; M Minunni; M Mascini
Journal:  Biosens Bioelectron       Date:  2004-12-16       Impact factor: 10.618

3.  In vitro selection of RNA molecules that bind specific ligands.

Authors:  A D Ellington; J W Szostak
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

Review 4.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

Authors:  Regina Stoltenburg; Christine Reinemann; Beate Strehlitz
Journal:  Biomol Eng       Date:  2007-06-16

Review 5.  Advances in aptamer screening technologies.

Authors:  Jianhua Yan; Hongjie Xiong; Shundong Cai; Nachuan Wen; Qunye He; Yanfei Liu; Dongming Peng; Zhenbao Liu
Journal:  Talanta       Date:  2019-03-04       Impact factor: 6.057

Review 6.  Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development.

Authors:  Tao Wang; Changying Chen; Leon M Larcher; Roberto A Barrero; Rakesh N Veedu
Journal:  Biotechnol Adv       Date:  2018-11-05       Impact factor: 14.227

Review 7.  Aptamer chemistry.

Authors:  Pascal Röthlisberger; Marcel Hollenstein
Journal:  Adv Drug Deliv Rev       Date:  2018-04-04       Impact factor: 15.470

8.  In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits.

Authors:  L C Griffin; G F Tidmarsh; L C Bock; J J Toole; L L Leung
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113

Review 9.  Aptamers as targeted therapeutics: current potential and challenges.

Authors:  Jiehua Zhou; John Rossi
Journal:  Nat Rev Drug Discov       Date:  2016-11-03       Impact factor: 84.694

10.  One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX.

Authors:  Andreas Nitsche; Andreas Kurth; Anna Dunkhorst; Oliver Pänke; Hendrik Sielaff; Wolfgang Junge; Doreen Muth; Frieder Scheller; Walter Stöcklein; Claudia Dahmen; Georg Pauli; Andreas Kage
Journal:  BMC Biotechnol       Date:  2007-08-15       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.